| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 298.24 | 263.46 | 13.201 | 301.88 | -1.205 |
| Gross Profit (Loss) | 92.99 | 85.74 | 8.455 | 96.51 | -3.647 |
| Operational Profit (Loss) | 63.89 | 130.17 | -50.918 | 76.73 | -16.734 |
| Net profit (Loss) | 61.96 | 117.87 | -47.433 | 73.93 | -16.19 |
| Total Comprehensive Income | 62.94 | 117.45 | -46.411 | 75.24 | -16.347 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 600.12 | 540.5 | 11.03 |
| Gross Profit (Loss) | 189.5 | 176.8 | 7.183 |
| Operational Profit (Loss) | 140.62 | 205.06 | -31.424 |
| Net profit (Loss) | 135.89 | 181.91 | -25.298 |
| Total Comprehensive Income | 138.19 | 181.76 | -23.971 |
| Total Shareholders Equity (after Deducting Minority Equity) | 1,987.44 | 1,914.68 | 3.8 |
| Profit (Loss) per Share | 0.85 | 1.14 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | – | – | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | Q2 2025 revenues increased by 13.2% year-on-year, reaching 298.24 million Saudi Riyals. This is up from 263.46 million Saudi Riyals in Q2 2024, and the growth is primarily due to:
1) Increased revenues from the medical services sector driven by more favorable terms in recently signed contracts with some clients. 2) Increased revenues from the pharmaceutical products sector. |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | Net profit for the second quarter of 2025 decreased by 47.4% year-on-year, reaching 61.96 million Saudi Riyals, compared to 117.87 million Saudi Riyals in Q2 2024. This decline in net profit is primarily attributed to:
1) Recording a 10.91 million Saudi Riyals provision for credit losses during Q2 2025 due to delayed collection of some receivables until after the current quarter. 2) Realization of exceptional, non-recurring gains of 55.27 million Saudi Riyals in the comparable quarter of the previous year (Q2 2024), which resulted from the sale of a vacant plot of land in Al Rayyan district, Riyadh. |
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is | Q2 2025 revenues decreased by 1.2% year-on-year, settling at 298.24 million Saudi Riyals. This decline is compared to 301.88 million Saudi Riyals in Q1 2025.
This downturn is primarily attributed to a drop in revenues from the medical services sector at the end of the current quarter, which coincided with the Eid al-Adha holiday and the start of the vacation season. |
| The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is | Net profit for the second quarter of 2025 decreased by 16.2% to 61.96 million Saudi Riyals, compared to 73.93 million Saudi Riyals in the first quarter of the same year. This decline is primarily attributable to:
1) A 1.2% decrease in net revenues in the current quarter compared to Q1 2025. 2) Recording a 10.91 million Saudi Riyals provision for credit losses during Q2 2025, resulting from delayed collection of some receivables until after this quarter. |
| The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is | Revenues for the first half of 2025 increased by 11.0% year-on-year, reaching 600.12 million Saudi Riyals, compared to 540.50 million Saudi Riyals in the same period of 2024. This rise is primarily attributed to:
1) Increased revenues from the medical services sector driven by more favorable terms in recently signed contracts with some clients. 2) Increased revenues from the pharmaceutical products sector. |
| The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is | Net profit for the first half of 2025 decreased by 25.3% year-on-year, reaching 135.89 million Saudi Riyals, compared to 181.91 million Saudi Riyals in the same period of 2024. This decline is primarily attributed to:
1) Recording a 10.91 million Saudi Riyals provision for credit losses during Q2 2025 due to delayed collection of some outstanding amounts. 2) Realization of exceptional, non-recurring gains of 55.27 million Saudi Riyals in Q2 2024, which resulted from the sale of a vacant plot of land in Al Rayyan district, Riyadh. |
| Statement of the type of external auditor’s report | Unmodified conclusion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | None |
| Reclassification of Comparison Items | None |
| Additional Information | None |
